Humulene

Humulene is the hops terpene. If you have smelled a fresh IPA, you have smelled it — and cannabis and hops are close enough relatives that the overlap is not a coincidence.

What it is

Humulene is a sesquiterpene, C₁₅H₂₄, which puts it in a different weight class from myrcene, limonene, and pinene. Sesquiterpenes are larger molecules, and they behave differently: they are less volatile, they persist longer in an opened jar, and they sit lower in a profile as a base note rather than a top note.

The smell is woody, dry, and herbal, with an earthy backbone. Outside cannabis it appears in hops, basil, cloves, coriander, and sage.

Humulene and beta-caryophyllene are frequently found together, and their biosynthesis is related — which is worth remembering when you try to attribute anything to one of them alone.

What you will see on a COA

Humulene carries the single most confusing naming collision on a cannabis lab report.

It is sometimes labelled α-caryophyllene (alpha-caryophyllene). This is not β-caryophyllene, which is a different compound with its own line and its own properties. If a report lists both "α-caryophyllene" and "β-caryophyllene", the first one is humulene. Record them separately.

Typical flower concentrations run 0.05% to 0.5%, with extracts sometimes higher. As a sesquiterpene it degrades more slowly than the monoterpenes above it, so in an older jar humulene may make up a larger share of what is left than the original report suggests — the bright notes go first and the woody base remains.

See caryophyllene for the compound it is most often confused with, and how to read a cannabis COA for where the terpene panel sits on the document.

What the research does and does not show

Humulene has a reasonably active preclinical literature. Cell and animal studies report effects on inflammatory markers, pain-related responses in animal models, antimicrobial activity in vitro, and cytotoxicity in cancer model systems.

A 2024 scoping review looked specifically at how much of that has translated, and the finding was the useful part: human studies involving isolated α-humulene are sparse. The preclinical base is genuinely broad; the clinical bridge has largely not been built.

There is also a structural problem with attributing anything to humulene from consumer experience. Because it so often travels with β-caryophyllene and other compounds in the same fraction, a humulene-forward batch is rarely humulene-forward and nothing else. Isolating its contribution is difficult in a laboratory and effectively impossible from a jar.

The user-reported association — that humulene-forward profiles feel steadier and less sharp than pinene or limonene-heavy ones — is a real pattern in what people say. It is not evidence of what the compound does.

How to actually find out

Humulene rewards patience more than most compounds, because it moves in a narrow range and travels with company.

Worth doing:

• Get the label right. If your source writes α-caryophyllene, that is humulene. Logging it under the wrong name quietly corrupts every comparison that follows.
• Record caryophyllene alongside it. They co-occur often enough that a humulene pattern needs checking against whether caryophyllene was also elevated.
• Accept that this one takes volume. Compounds present at a few tenths of a percent, varying across a narrow band, need more sessions before a difference is distinguishable from noise.

If humulene content is associated with something in your record across enough sessions and enough products, that association is yours. The literature is not currently in a position to have told you.